Journal of Neuropathology & Experimental Neurology · 2014 · 30 citations · 39 references
Life SciencesImmunologyOncologyCancer ImmunologyImmunopathologyTumor ImmunologyAntigen Receptor Gene RearrangementCentral Nervous System LymphomaLymphoid NeoplasmsLymphoid TumorsTumor AntigensTumor-associated AntigensAntibody Repertoire AnalysisB Cell Receptor Gene RearrangementB Cell Receptor RecognitionGermline Immunoglobulin Gene UsageImmunoglobulin Heavy Chain RearrangementImmunoglobulin Light Chain RearrangementSomatic Hypermutation In LymphomagenesisTumor Cell Proliferation
Primary lymphoma of the central nervous system (PCNSL) is a diffuse large B-cell lymphoma confined to the CNS. It has been hypothesized that antigen(s) in the CNS may trigger tumor cell proliferation. Because efforts to identify potential antigens have been unsuccessful to date, we studied the B-cell receptor in detail in a comprehensive series of 50 PCNSLs to obtain indirect information on potential antigens. Potentially functional V-D-J rearrangements were identified in all PCNSLs analyzed. Immunoglobulin heavy-chain variable gene segment (IGHV), IGHV4, was the predominant family used by 66% (33 of 50) of PCNSLs with a preferential rearrangement of the IGHV4-34 gene segment (18 [55%] of 33). The IGHV genes showed mutation frequencies from 0% to 29%, with a high average mutation frequency of 10%. In addition to 48% (24 of 50) of PCNSLs being highly mutated, 22% (11 of 50) defined a low-level mutated group. Antigen selection of the tumor cells or their precursors was indicated by replacement/silent mutation ratios and ongoing somatic hypermutation. Complementarity determining region 3 length and composition as well as the lack of stereotyped B-cell receptors suggest involvement of several antigens instead of a unique antigen recognized by the tumor cells.
39
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
R. Eric Davis, Vu N. Ngo, Georg Lenz et al. · Nature · 2010 · 1.6K citations · Full text
Medicine, Hematology, Oncology +14
Ulf Klein, Klaus Rajewsky, Ralf Küppers · The Journal of Experimental Medicine · 1998 · 1.2K citations · Full text
IMGT(R), the international ImMunoGeneTics information system(R)
Marie‐Paule Lefranc, Véronique Giudicelli, Chantal Ginestoux et al. · Nucleic Acids Research · 2008 · 1.1K citations · Full text
Life Sciences, Genetics, Immunology +14
Diversity in the CDR3 Region of VH Is Sufficient for Most Antibody Specificities
Mark M. Davis · Immunity · 2000 · 804 citations · Full text
Hendrik Pels, Ingo G.H. Schmidt‐Wolf, Axel Glasmacher et al. · Journal of Clinical Oncology · 2003 · 423 citations
Medicine, Oncology, Pharmacotherapy +13